SCHEMBL28671519

SCHEMBL28671519

COc1ccc(Cn2c(N)nc3c(c2=O)CCN(C(=O)O)C3)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLPP Q16740 3/20 0.44
▸ PDE5A O76074 1/20 0.43
▸ PDE4A P27815 1/20 0.43
▸ PDE4B Q07343 1/20 0.43
▸ PDE4C Q08493 1/20 0.43
▸ PDE4D Q08499 1/20 0.43
▸ PNP P00491 1/20 0.43
▸ TP53 P04637 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ CFTR P13569 2/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ LMNA P02545 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ FAAH O00519 1/20 0.39
▸ GAA P10253 3/20 0.39
▸ POLB P06746 2/20 0.39
▸ PKM P14618 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ CASP1 P29466 2/20 0.39
▸ CASP7 P55210 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22410754 0.88 P2RX3 (0.51) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL22424242 0.84 MAPT (0.44) TP53SMN1; SMN2ALDH1A1LMNATSHR
SCHEMBL22424576 0.82 PDE5A (0.44) CLPPPDE5APDE4APDE4BPDE4C
SCHEMBL22424057 0.77 PNP (0.48) CLPPPDE5APDE4APDE4BPDE4C
SCHEMBL22717352 0.75 CLPP (0.46) CLPPTP53POLBMAPTFABP4
SCHEMBL28984535 0.75 PTGDR2 (0.53) CLPPTP53ALDH1A1LMNATSHR
SCHEMBL28669319 0.71 CLPP (0.44) CLPPPDE5ATP53ALDH1A1LMNA
SCHEMBL22424014 0.71 PRLHR (0.51) CLPPTP53SMN1; SMN2ALDH1A1LMNA
SCHEMBL22367284 0.69 GAA (0.51) SMN1; SMN2ALDH1A1LMNAFAAHGAA
SCHEMBL28948269 0.69 KCNK3 (0.44) PDE4BPDE4DTP53SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113710667-A Fused cyclic pyrimidinone derivatives for the treatment of HBV infection or HBV induced diseases 爱尔兰詹森科学公司 2021-11-26 — — CN disclosed
Send feedback